This inventor holds 1 USPTO granted patent. Top assignees: Hitachi High-Tech Corporation, Showa University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2026
Title: The Innovations of Yoshihiro Nagase
Introduction
Yoshihiro Nagase is a prominent inventor based in Tokyo, Japan. He is known for his significant contributions to the field of immunostaining, which plays a crucial role in pathological diagnosis and research. His innovative approach has led to the development of a unique patent that enhances the efficiency and effectiveness of sample analysis.
Latest Patents
Yoshihiro Nagase holds 1 patent for an immunostaining method, sample exchange chamber, and charged particle beam apparatus. This invention provides a sample exchange chamber that includes a container for introducing a substrate with a sample, a specific solution inlet for staining, a cleaning liquid inlet for sample cleaning, an evacuation port for removing air, a drain port, and a sterilization mechanism to ensure the sample and container remain uncontaminated. This innovative design aims to facilitate novel immunostaining techniques for improved pathological diagnosis and research.
Career Highlights
Throughout his career, Yoshihiro Nagase has worked with esteemed institutions such as Showa University and Hitachi High-Tech Corporation. His experience in these organizations has allowed him to refine his skills and contribute to advancements in technology and research methodologies.
Collaborations
Yoshihiro has collaborated with notable colleagues, including Takashi Takaki and Dedong Kang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Yoshihiro Nagase's contributions to the field of immunostaining exemplify the impact of innovative thinking in scientific research. His patented inventions continue to influence the way samples are analyzed, paving the way for advancements in pathological diagnosis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile